跳到正文
原文
Endpoints News 生物医药· Kyle LaHucik·· 2026-10-16AI 评分30

Eli Lilly 神经科学负责人称对伊博格aine研发投资感兴趣

Lilly interested in ibogaine investments, its neuro leader says

AI 导读

Eli Lilly 的神经科学负责人卡罗尔·德汉布兰在周四的一场迷幻药会议上表示,该公司对研发“改善伊博格aine特性”的项目感兴趣。

正文

Eli Lil­ly is in­ter­est­ed in R&D ef­forts to “im­prove the pro­file of ibo­gaine,” the phar­ma gi­ant’s neu­ro­science pres­i­dent said at a psy­che­delics con­fer­ence Thurs­day.

Ca­r­ole …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news